DRI / RDA for B-Vitamins
Typical Food Sources for all B-Vitamins:
Brewer's yeast, unrefined whole grains, liver, all meats, eggs, green leafy vegetables, beans, nuts, seeds.
| Vitamin B1 - Thiamine (Thiamine Pyrophosphate) (Synthetic derivatives: Benfotiamine, Allithiamine, Fursultiamine, Prosultiamine, Sulbutiamine) |
Vitamin B2 - Riboflavin (Riboflavin 5'-Phosphate) |
||||
Vitamin B1 - Thiamine
|
|||||
|
AGE
0-6 months 6-12 months 1-3 years 4-8 years 9-13 years male 14+ years male 9-13 years fem. 14-18 years fem. 19+ years fem. pregnant lactating ------------------- UL Therapeutic Range |
DRI (RDA)
0.2mg AI 0.3mg AI 0.5mg 0.6mg 0.9mg 1.2mg 0.9mg 1.0mg 1.1mg 1.4mg 1.4mg N/A 50mg - 1,000 mg + |
Vitamin B2 - Riboflavin
(Riboflavin 5'-Phosphate)
|
AGE
0-6 months 6-12 months 1-3 years 4-8 years 9-13 years male 14+ years male 9-13 years fem. 14-18 years fem. 19+ years fem. pregnant lactating ------------------- UL Therapeutic Range |
DRI (RDA)
0.3mg AI 0.4mg AI 0.5mg 0.6mg 0.9mg 1.3mg 0.9mg 1.0mg 1.1mg 1.4mg 1.6mg N/A 50mg - 500mg + |
Table key
- DRI
- Dietary Reference Intake
- RDA
- Recommended Dietary Allowance
- AI
- Adequate Intake
- UL
- Tolerable Upper Intake Level
Doses reported in clinical or therapeutic use in the published literature. These are a record of doses that have been administered, in many cases as medication rather than as a nutrient, and they may exceed the UL. They are not intakes recommended by this site.
| Vitamin B3/4 - Niacin / Niacinamide | Vitamin B5 - Pantethine / Pantothenic Acid (also called Calcium Pantothenate) |
||||
Vitamin B3/4 - Niacin / Niacinamide
|
Vitamin B5 - Pantethine / Pantothenic Acid
|
||||
|
AGE
0-6 months 6-12 months 1-3 years 4-8 years 9-13 years male 14+ years male 9-13 years fem. 14+ years fem. pregnant lactating ------------------- UL Therapeutic Range |
DRI (RDA)
1.7mg AI 1.8mg AI 2mg AI 3mg AI 4mg AI 5mg AI 4mg AI 5mg AI 6mg AI 7mg AI N/A 250mg - 20,000mg + |
Table key
- DRI
- Dietary Reference Intake
- RDA
- Recommended Dietary Allowance
- AI
- Adequate Intake
- UL
- Tolerable Upper Intake Level
Doses reported in clinical or therapeutic use in the published literature. These are a record of doses that have been administered, in many cases as medication rather than as a nutrient, and they may exceed the UL. They are not intakes recommended by this site.
| Vitamin B6 - Pyridoxine (Pyridoxal-5-Phosphate / P5P) |
Vitamin B7 - Biotin (N-Carboxybiotinyl Lysine / Biotinyl-5'AMP) |
||||
Vitamin B6 - Pyridoxine
|
|||||
|
AGE
0-6 months 6-12 months 1-3 years 4-8 years 9-13 years male 14-18 years male 19-50 years male 51+ years male 9 -13 years fem. 14-18 years fem. 19-50 years fem. 51+ years fem. pregnant lactating ------------------- UL Therapeutic Range |
DRI (RDA)
0.1mg AI 0.3mg AI 0.5mg 0.6mg 1.0mg 1.3mg 1.3mg 1.7mg 1.0mg 1.2mg 1.3mg 1.5mg 1.9mg 2.0mg 30mg - 100mg 100mg - 2,000mg + |
Vitamin B7 - Biotin
(N-Carboxybiotinyl Lysine / Biotinyl-5'AMP)
|
AGE
0-6 months 6-12 months 1-3 years 4-8 years 9-13 years male 14-18 years male 19-50 years male 51+ years male 9 -13 years fem. 14-18 years fem. 19-50 years fem. 51+ years fem. pregnant lactating ------------------- UL Therapeutic Range |
DRI (RDA)
5 mcg AI 6 mcg AI 8 mcg AI 12 mcg AI 20 mcg AI 25 mcg AI 30 mcg AI 30 mcg AI 20 mcg AI 25 mcg AI 30 mcg AI 30 mcg AI 30 mcg AI 35 mcg AI N/A 50 mcg - 15,000 mcg + |
Table key
- DRI
- Dietary Reference Intake
- RDA
- Recommended Dietary Allowance
- AI
- Adequate Intake
- UL
- Tolerable Upper Intake Level
Doses reported in clinical or therapeutic use in the published literature. These are a record of doses that have been administered, in many cases as medication rather than as a nutrient, and they may exceed the UL. They are not intakes recommended by this site.
| Vitamin B9 - Folate / Folic Acid (L-5-Methyltetrahydrofolate / L-5-MTHF) |
Vitamin B10 - PABA (Para-Aminobenzoic Acid) |
||||
Vitamin B9 - Folate / Folic Acid
|
|||||
|
AGE
0-6 months 6-12 months 1-3 years 4-8 years 9-13 years male 14+ years male 9-13 years fem. 14+ years fem. pregnant lactating ------------------- UL Therapeutic Range |
DRI (RDA)
65 mcg AI 80 mcg AI 150 mcg 200 mcg 300 mcg 400 mcg 300 mcg 400 mcg 600 mcg - 5mg (high risk) 500 mcg 300 mcg - 1,000 mcg 400 mcg - 20,000 mcg + |
Vitamin B10 - PABA
(Para-Aminobenzoic Acid)
|
AGE
0-6 months 6-12 months 1-3 years 4-8 years 9-13 years male 14+ years male 9-13 years fem. 14+ years fem. ------------------- UL Therapeutic Range |
DRI (RDA)
1mg - 5mg 5mg - 40mg 1mg - 5mg 5mg - 40mg N/A 150mg - 900mg + |
Table key
- DRI
- Dietary Reference Intake
- RDA
- Recommended Dietary Allowance
- AI
- Adequate Intake
- UL
- Tolerable Upper Intake Level
Doses reported in clinical or therapeutic use in the published literature. These are a record of doses that have been administered, in many cases as medication rather than as a nutrient, and they may exceed the UL. They are not intakes recommended by this site.
| Vitamin B8 - Inositol | Vitamin B11 - Choline | ||||
Vitamin B8 - Inositol
The DRI (AI) shown applies to Choline (B11); no DRI or Tolerable Upper Intake Level has been set for Inositol (B8).
|
Vitamin B11 - Choline
Lecithin: DRI (RDA): none - UL: n/a - Therapeutic Range: 1,200mg - 7,200mg +
|
||||
| Best time to take Inositol: Morning - afternoon; with food. | Best time to take Choline: Morning - afternoon; with food. | ||||
High/Low Levels / Deficiency / Toxicity - Symptoms and Risk Factors: |
|||||
| Low Inositol: Oxidative cell damage, cardiovascular disease, liver disease, low bile production, low blood pressure, low total and low HDL cholesterol, mental disorders, peripheral neuropathy, panic-anxiety attacks, agoraphobia, bulimia, unipolar and bipolar depression, obsessive-compulsive disorder (up to 18g daily), polycystic ovary syndrome (PCOS), insulin resistance. | Low Choline: Low blood pressure, Oxidative cell damage, cardiovascular disease, liver disease, low bile production, low total and low HDL cholesterol, mental disorders, gallstones, poor memory / reduced learning capacity, kidney stones. | ||||
| High Inositol: Nausea, vomiting, dizziness, high blood pressure, liver disease, kidney disease, cardiovascular disease, increased magnesium requirements, may increase potassium requirements, acne-like skin rash. | High Choline: Vomiting, nausea, dizziness, high blood pressure, liver disease, kidney disease, cardiovascular disease, increased magnesium requirements, may increase potassium requirements, acne-like skin rash. | ||||
Table key
- DRI
- Dietary Reference Intake
- RDA
- Recommended Dietary Allowance
- AI
- Adequate Intake
- UL
- Tolerable Upper Intake Level
Doses reported in clinical or therapeutic use in the published literature. These are a record of doses that have been administered, in many cases as medication rather than as a nutrient, and they may exceed the UL. They are not intakes recommended by this site.